187 related articles for article (PubMed ID: 25955465)
41. [Subacute cognitive impairment and urinary retention due to primary central nervous system post-transplant lymphoproliferative disorder: a case report].
Yokoyama N; Kanbayashi T; Kobayashi S; Ishida T; Sonoo M
Rinsho Shinkeigaku; 2021 Nov; 61(11):750-755. PubMed ID: 34657922
[TBL] [Abstract][Full Text] [Related]
42. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.
Tiede C; Maecker-Kolhoff B; Klein C; Kreipe H; Hussein K
Transplantation; 2013 Feb; 95(3):479-88. PubMed ID: 23296147
[TBL] [Abstract][Full Text] [Related]
43. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
44. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
[TBL] [Abstract][Full Text] [Related]
45. Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.
Valencia-Sanchez C; Steenerson KK; Kelemen K; Orenstein R; Kusne S; Grill MF
J Neurovirol; 2019 Apr; 25(2):280-283. PubMed ID: 30607891
[TBL] [Abstract][Full Text] [Related]
46. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center.
Angel LF; Cai TH; Sako EY; Levine SM
Ann Transplant; 2000; 5(3):26-30. PubMed ID: 11147026
[TBL] [Abstract][Full Text] [Related]
47. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW
Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085
[TBL] [Abstract][Full Text] [Related]
48. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
[No Abstract] [Full Text] [Related]
49. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
50. Management of post-transplant lymphoproliferative disorders.
DeStefano CB; Desai SH; Shenoy AG; Catlett JP
Br J Haematol; 2018 Aug; 182(3):330-343. PubMed ID: 29741774
[TBL] [Abstract][Full Text] [Related]
51. Primary Central Nervous System Posttransplant Lymphoproliferative Disease in a Bilateral Transfemoral Lower Extremity Transplantation Recipient.
Cavadas PC; Thione A; Blanes M; Mayordomo-Aranda E
Am J Transplant; 2015 Oct; 15(10):2758-61. PubMed ID: 25968917
[TBL] [Abstract][Full Text] [Related]
52. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
53. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
54. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
55. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
56. Posttransplant lymphoproliferative disorder.
Everly MJ; Bloom RD; Tsai DE; Trofe J
Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
[TBL] [Abstract][Full Text] [Related]
57. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
Twombley K; Pokala H; Ardura MI; Harker-Murray P; Johnson-Welch SF; Weinberg A; Seikaly M
Pediatr Transplant; 2012 Sep; 16(6):E201-9. PubMed ID: 22646132
[TBL] [Abstract][Full Text] [Related]
58. Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.
Paranjothi S; Yusen RD; Kraus MD; Lynch JP; Patterson GA; Trulock EP
J Heart Lung Transplant; 2001 Oct; 20(10):1054-63. PubMed ID: 11595560
[TBL] [Abstract][Full Text] [Related]
59. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
[TBL] [Abstract][Full Text] [Related]
60. Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation.
Snavely NR; Sonabend M; Rosen T
Dermatol Online J; 2007 Oct; 13(4):7. PubMed ID: 18319004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]